Kathleen Carroll, PhD

Albert E. Kent Professor of Psychiatry; Director of Psychosocial Research, Division of Addictions; Principal Investigator, Psychotherapy Development Center for Drug Abuse

Departments & Organizations

Psychiatry: Division of Addictions | Division of Substance Abuse | Neuroscience Research Training Program (NRTP) | Psychology Section | Psychotherapy Development Center | Substance Abuse Research

Drug use, Addiction, and HIV Research Scholars (DAHRS)

Yale Medicine

Office of Cooperative Research


Dr. Kathleen M. Carroll graduated summa cum laude from Duke University, received her Ph.D. in clinical psychology in 1988 from the University of Minnesota, and completed her pre-doctoral training at the Yale University School of Medicine’s Division of Substance Abuse, where she was promoted to Professor in 2002. She is Principal Investigator of the Center for Psychotherapy Development at Yale, NIDA’s only Center devoted to behavioral therapies research, and since 1999 she has been Principal Investigator of the New England Node of the National Institute on Drug Abuse’s Clinical Trials Network. Dr. Carroll is the author of over 300 peer-reviewed publications as well as numerous chapters and books.   Her research has focused on the development and evaluation of behavioral treatments and combinations of behavioral therapies and pharmacotherapies to improve treatment outcomes for individuals with opioid use disorders.  

Education & Training

PhD University of Minnesota (1988)
BS Duke University (1980)
Predoctoral fellow Yale University School of Medicine

Honors & Recognition

  • John P Brantner Endowed LectureUniversity of Minnesota (2015)

  • Distinguished Speaker AwardBoston University Department of Psychology (2011)

  • Highly Cited ResearcherThompson ISI (2008)

  • Norman E. Zinberg Award & Memorial LectureHarvard University School of Medicine (2007)

  • The Society LecturerThe Society for the Study of Addiction (2005)

  • Distinguished Scientific Contributions to Education and Training AwardAmerican Psychological Association, Division 50 (2005)

  • MERIT award (Method to Enhance Research in Time)NIH (2003)

  • FellowDivision 28 (Psychopharmacology), APA (2002)

  • Senior Scientist Award (K05)NIDA (2000)

  • Distinguished Clinical Research Scholar on the Addictions,American Academy of Addiction Psychiatry (AAAP) (1999)

  • Predoctoral FellowshipAmerican Association of University Women (1986)

  • Phi Beta KappaDuke University (1979)

Professional Service

  • National Academy of Medicine (2018 - 2019) Committee on Medications to Treat Opioid Use Disorder

  • Journal of Studies on Alcohol and Drugs (2015 - Present) Editor

  • National Academy of Sciences, Institute of Medicine (2010 - 2012) Committee on Readjustment Needs of Military Personnel, Veterans and their Families

  • Yale University School of Medicine (2008 - 2011) Scholar Awards Committee

  • College of Problems on Drug Dependence (2007 - Present) Board of Directors, 2016-2018

  • Division 50, Addictions (2006 - 2010) Chairperson

  • American Psychological Association, Division 50 (2002 - 2005) President

  • American Psychological Association (2001 - 2009) Psychological Assessment

  • Yale University School of Medicine (2001 - 2004) Term Appointments and Promotions Committee

  • NIDA (2000 - Present) Reviewer


  • International Scientific Committee France (2011)

    Annales Medico-Psychologiques

  • Update on addiction treatment research Paris, France (2009 - 2009)

    Plenary session in Les Journees de L’Albatros : Actualities de la researche clinique et therapeutique en addictologie.

  • Addiction Treatment Trieste, Italy (2009)

    Comitato Scientifico del Dipartimento Politiche Antidroga (Member, Scientific Advisory Committee to the Department of Drug Policy, Government of Italy

  • Addiction and Treatment Vienna, Austria (2007)

    Consultant to United Nations Office of Drug and Crime (UNODC)

Edit this profile